Rheumatoid Arthritis Therapeutics Market

1
Pune, India, April 26, 2019 - Exhibiting a high
prevalence for rheumatoid arthritis, North
America is forecast to lead the global rheumatoid
arthritis therapeutics market in a recent
report. In a report, titled RHEUMATOID ARTHRITIS
THERAPEUTICS GLOBAL MARKET ANALYSIS, INSIGHTS
AND FORECAST, 2018-2025, Fortune Business
Insights identifies numerous factors enabling
growth in the market. According to the report,
the global rheumatoid arthritis therapeutics
market is anticipated to exhibit 4.6 CAGR and
reach valuation of US 33,958.4 Mn in 2025 from
US 23,822.5 Mn in 2017. North America to Lead
Global Market with Rising Prevalence of
Rheumatoid Arthritis The North America market
was worth US 9,929.6 Mn in 2017. It is expected
to show steady rise owing to the rising
prevalence of rheumatoid arthritis and increasing
awareness about this disorder. Adding to that,
governments of North America are investing huge
sums for improving the healthcare and medical
facilities in the region. This is helping the
rheumatoid arthritis therapeutics market to grow
at an impressive pace in North America. On the
other side, the demand for rheumatoid arthritis
treatment is likely to grow at a considerable
pace in Asia Pacific. This is owing to the entry
of new drugs, especially biologics, for the
treatment of rheumatoid arthritis in the market.
This, coupled with expansion of healthcare and
medical infrastructure in emerging nations, is
likely to help rheumatoid arthritis therapeutic
market in Asia Pacific gain more momentum. Get
Sample PDF https//www.fortunebusinessinsights.co
m/enquiry/request-sample-pdf/rheumatoid-
arthritis-therapeutics-market-100488
Biologics Segment to Account for Highest Market
Share In terms of product type, the biologics
segment is anticipated to hold the highest share
in the market in terms of revenue during the
forecast period. In 2017, the biologics segment
held 87.6 of the rheumatoid arthritis
therapeutics market. This is because biologics
targeting specific components of the immune
response system help to slow down the rate of
progression of arthritis in the patient. They
also help in improving the physical functionality
of patients and are cost efficient as compared
to other treatment methods, which helps to
increase the demand for biologics in the
market. Presence of expensive drugs for
rheumatoid arthritis treatment, coupled with,
favorable reimbursement policies are factors
propelling the global market. Developing
countries are making efforts to improve their
medical infrastructure in order to provide
medical aid for diseases such as chronic
arthritis and other chronic diseases and this is
another key factor helping the market to
grow. Increasing Number of Medical Professionals
Facilitating Rheumatoid Arthritis Treatment
2
Rise in geriatric population is a key factor
enabling growth in the market. The prevalence of
arthritis is considerably high among aged
population, which is why a rise in their number
is expected to bode well for the overall market.
In case of rheumatoid arthritis, improvement in
diagnostic procedures is favoring growth of the
global market for rheumatoid arthritis.
Furthermore, the market is expected to gain from
the spread of various awareness programs and
increasing number of skilled healthcare
professionals. In 2017, AbbVie Inc., emerged
dominant in the global rheumatoid arthritis
therapeutics market. At present there are
numerous market players operating in the market,
out of which about ten players hold 80 of the
market. In order to gain competitive advantage,
some of the leading companies are focusing on
investing increasingly towards research and
development of novel therapeutics. Some of the
other key players operating in the global
rheumatoid arthritis therapeutics market are
Gilead Sciences, Inc., F. Hoffmann-La Roche AG,
Eli Lilly and Company, UCB S.A., Bristol-Myers
Squibb Company, Amgen Inc., Pfizer Inc., Celgene
Corporation, and Johnson Johnson Services,
Inc. About Us Fortune Business Insights offers
expert corporate analysis and accurate data,
helping organizations of all sizes make timely
decisions. We tailor innovative solutions for our
clients, assisting them address challenges
distinct to their businesses. Our goal is to
empower our clients with holistic market
intelligence, giving a granular overview of the
market they are operating in. Our reports
contain a unique mix of tangible insights and
qualitative analysis to help companies achieve
sustainable growth. Our team of experienced
analysts and consultants use industry-leading
research tools and techniques to compile
comprehensive market studies, interspersed with
relevant data. At Fortune Business Insights we
aim at highlighting the most lucrative growth
opportunities for our clients. We therefore
offer recommendations, making it easier for them
to navigate through technological and
market-related changes. Our consulting services
are designed to help organizations identify
hidden opportunities and understand prevailing
competitive challenges. Browse Complete
Report https//www.fortunebusinessinsights.com/in
dustry-reports/rheumatoid-arthritis-therapeutics-
market-100488